AQR Capital Management
RCKT icon

AQR Capital Management’s Rocket Pharmaceuticals RCKT Stock Holding History

AQR Capital Management’s Portfolio RCKT Stock Details RCKT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$11M Buy
3,069,930
+2,366,402
+336% +$9.41M 0.01% 1296
2025
Q4 		$2.47M Sell
703,528
-169,719
-19% -$581K ﹤0.01% 2006
2025
Q3 		$2.85M Buy
873,247
+95,579
+12% +$301K ﹤0.01% 1772
2025
Q2 		$1.91M Buy
777,668
+614,046
+375% +$3.11M ﹤0.01% 1803
2025
Q1 		$1.09M Buy
163,622
+97,758
+148% +$966K ﹤0.01% 1968
2024
Q4 		$828K Buy
65,864
+46,956
+248% +$707K ﹤0.01% 1994
2024
Q3 		$349K Buy
+18,908
New +$387K ﹤0.01% 2323
2024
Q2 		– Sell
-10,118
Closed -$273K – 2664
2024
Q1 		$273K Buy
10,118
+2,060
+26% +$58.5K ﹤0.01% 2159
2023
Q4 		$241K Buy
+8,058
New +$178K ﹤0.01% 2146

Other funds holding RCKT

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Citigroup
Citigroup New York $157B AUM 32.99% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
MC
Maverick Capital Dallas, Texas $8.6B AUM 48.76% 1-Year Est. Return
NM
Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return